
selectscience.vercel.app/article/cytiva-launches-new-aekta-readyflux-system-for-smaller-scale-manufacturing
Preview meta tags from the selectscience.vercel.app website.
Linked Hostnames
7- 152 links toselectscience.vercel.app
- 9 links towww.selectscience.net
- 1 link tothescientistschannel.com
- 1 link towww.cytiva.com
- 1 link towww.facebook.com
- 1 link towww.linkedin.com
- 1 link towww.twitter.com
Thumbnail

Search Engine Appearance
Cytiva launches new ÄKTA readyflux system for smaller scale manufacturing
Cytiva is expanding its ÄKTA portfolio with the addition of a system designed to optimize smaller-scale manufacturing. The ÄKTA readyflux TFF system 500 was developed in direct response to customer feedback indicating a rising need for efficient handling of low-volume applications in advanced therapeutic development, including viral vectors, mAbs, ADCs, and mRNA-based therapeutics.
Bing
Cytiva launches new ÄKTA readyflux system for smaller scale manufacturing
Cytiva is expanding its ÄKTA portfolio with the addition of a system designed to optimize smaller-scale manufacturing. The ÄKTA readyflux TFF system 500 was developed in direct response to customer feedback indicating a rising need for efficient handling of low-volume applications in advanced therapeutic development, including viral vectors, mAbs, ADCs, and mRNA-based therapeutics.
DuckDuckGo
Cytiva launches new ÄKTA readyflux system for smaller scale manufacturing
Cytiva is expanding its ÄKTA portfolio with the addition of a system designed to optimize smaller-scale manufacturing. The ÄKTA readyflux TFF system 500 was developed in direct response to customer feedback indicating a rising need for efficient handling of low-volume applications in advanced therapeutic development, including viral vectors, mAbs, ADCs, and mRNA-based therapeutics.
General Meta Tags
5- titleCytiva launches new ÄKTA readyflux system for smaller scale manufacturing
- charsetutf-8
- viewportwidth=device-width, initial-scale=1
- descriptionCytiva is expanding its ÄKTA portfolio with the addition of a system designed to optimize smaller-scale manufacturing. The ÄKTA readyflux TFF system 500 was developed in direct response to customer feedback indicating a rising need for efficient handling of low-volume applications in advanced therapeutic development, including viral vectors, mAbs, ADCs, and mRNA-based therapeutics.
- next-size-adjust
Open Graph Meta Tags
3- og:titleCytiva launches new ÄKTA readyflux system for smaller scale manufacturing
- og:descriptionCytiva is expanding its ÄKTA portfolio with the addition of a system designed to optimize smaller-scale manufacturing. The ÄKTA readyflux TFF system 500 was developed in direct response to customer feedback indicating a rising need for efficient handling of low-volume applications in advanced therapeutic development, including viral vectors, mAbs, ADCs, and mRNA-based therapeutics.
- og:imagehttps://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/f9b827d0e24d30e6f019533037b1f6251142db15-250x150.png?rect=0,10,250,131&w=1200&h=630
Twitter Meta Tags
4- twitter:cardsummary_large_image
- twitter:titleCytiva launches new ÄKTA readyflux system for smaller scale manufacturing
- twitter:descriptionCytiva is expanding its ÄKTA portfolio with the addition of a system designed to optimize smaller-scale manufacturing. The ÄKTA readyflux TFF system 500 was developed in direct response to customer feedback indicating a rising need for efficient handling of low-volume applications in advanced therapeutic development, including viral vectors, mAbs, ADCs, and mRNA-based therapeutics.
- twitter:imagehttps://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/f9b827d0e24d30e6f019533037b1f6251142db15-250x150.png?rect=0,10,250,131&w=1200&h=630
Link Tags
13- canonicalhttps://www.selectscience.net/article/cytiva-launches-new-aekta-readyflux-system-for-smaller-scale-manufacturing
- preload/_static/images/logo.svg
- preload/_next/static/chunks/webpack-7b1c391297a1ada0.js
- preloadhttps://cookie-cdn.cookiepro.com/scripttemplates/otSDKStub.js
- preloadhttps://assets.zephr.com/zephr-browser/1.6.2/zephr-browser.umd.js
Links
166- https://selectscience.vercel.app
- https://selectscience.vercel.app/aboutus
- https://selectscience.vercel.app/antibodies
- https://selectscience.vercel.app/article/chempartner-s-bispecific-adc-platform-accelerates-oncology-drug-discovery
- https://selectscience.vercel.app/article/how-multiomics-and-ai-advance-drug-discovery